Screener
Arcutis Biotherapeutics, Inc. ARQT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s free cash flow?
- Arcutis Biotherapeutics, Inc. (ARQT) reported free cash flow of $12.48M in Q2 2026.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s free cash flow?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s free cash flow has grown at a -13.8% compound annual growth rate (CAGR), from -$175.62M to -$112.3M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Arcutis Biotherapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude